Pedro Ruiz

Development of BRD4 inhibitors as anti-inflammatory agents and antidotes for arsenicals.

L. Zhai, M. Athar, J. R. Bostwick, 2022, Bioorganic & medicinal chemistry letters.

Development of novel small molecules for the treatment of ALS.

M. Suto, Bini Mathew, V. Pathak, 2020, Bioorganic & medicinal chemistry letters.

A Novel Approach To Identify Inhibitors of Iron Acquisition Systems of Pseudomonas aeruginosa

N. M. Nebane, P. Vinson, Avishek Mitra, 2022, Microbiology spectrum.

Lactic acid production by Lactobacillus sp. from biodiesel derived raw glycerol

D. M. Velasco, Pedro Ruiz, Yessica Prada Palomo, 2012 .

Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS.

Shilpa Dutta, M. Suto, R. Cowell, 2020, European journal of medicinal chemistry.

Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability

Jonathan R Roth, J. Day, Hunter B. Dean, 2023, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.